Homepage

Integra LifeSciences Holdings Corporation

IART NASDAQ Categories PDF
Healthcare · Medical - Devices · United States · Updated May 10, 8:17pm
$13.92
Price
$1.1B
Market Cap
4,396
Employees
1.08
Beta
Mojdeh Poul
CEO
Business Description

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Business History
Price Overview
Last updated: May 11, 2026 1:51pm (just now)
$13.60
-0.32 (-2.30%)
Day Range
$12.94 – $14.08
52-Week Range
$8.70 – $16.49
50-Day MA
$10.26
200-Day MA
$12.45
Volume
536,829.84
Analyst Price Targets
Low $12.00
Consensus $12.00
High $12.00
(15 analysts)
Share Structure
Outstanding 77,796,903.00
Float 58,718,768.00
Free Float 75.5%
Normal free float — 75.5% of shares trade freely, ~24.5% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-2.07
Stock Price: $13.92
EPS (Diluted): -6.73
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
0.91
Stock Price: $13.92
Total Equity: $1.04B
Shares: 76,753,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-10.45
Market Cap: $1.08B
Total Debt: $1.86B
Cash: $235.05M
EBITDA: -$326.20M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$2.8B
Market Cap: $1.08B
Total Debt: $1.86B
Cash: $235.05M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
51.7%
Gross Profit: $845.23M
Revenue: $1.64B
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
4.2%
Operating Income: $68.32M
Revenue: $1.64B
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-31.6%
Net Income: -$516.47M
Revenue: $1.64B
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-47.6%
Net Income: -$516.47M
Total Equity: $1.04B
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
3.5%
Operating Income: $68.32M
Tax Rate: 8.3%
Equity: $1.04B
Total Debt: $1.86B
Cash: $235.05M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
2.54
Current Assets: $1.16B
Current Liabilities: $455.98M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
1.78
Short-Term Debt: $126.55M
Long-Term Debt: $1.73B
Total Debt: $1.86B
Total Equity: $1.04B
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$21.31
Revenue: $1.64B
Shares: 76,753,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$13.60
Total Equity: $1.04B
Shares: 76,753,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$-0.40
Operating CF: $50.38M
CapEx: -$81.44M
Shares: 76,753,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $13.92
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$516.47M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares IART against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $1.5B $1.6B $1.5B $1.6B $1.6B
Cost of Revenue $597.8M $587.4M $656.8M $728.5M $790.0M
Gross Profit $944.6M $970.3M $884.7M $882.1M $845.2M
Operating Expenses $747.4M $731.4M $773.2M $853.7M $776.9M
Operating Income $197.2M $238.9M $111.5M $28.4M $68.3M
Net Income $169.1M $180.6M $67.7M -$6.9M -$516.5M
EBITDA $366.3M $384.6M $256.0M $193.3M -$326.2M
EPS $2.00 $2.18 $0.87 $-0.09 $-6.73
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $513.4M $456.7M $276.4M $246.4M $235.0M
Total Current Assets $1.2B $1.2B $1.1B $1.1B $1.2B
Total Assets $3.8B $3.9B $3.8B $4.0B $3.6B
Current Liabilities $340.0M $320.9M $307.0M $922.1M $456.0M
Long-Term Debt $1.5B $1.4B $1.5B $1.2B $1.7B
Total Liabilities $2.1B $2.1B $2.2B $2.5B $2.6B
Total Equity $1.7B $1.8B $1.6B $1.5B $1.0B
Retained Earnings $698.6M $879.1M $946.9M $939.9M $423.4M
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $312.4M $264.5M $140.0M $129.4M $50.4M
Capital Expenditure -$48.1M -$47.1M -$66.9M -$104.4M -$81.4M
Free Cash Flow $264.3M $217.4M $73.1M $25.0M -$31.1M
Acquisitions (net) -$113.4M -$27.5M $0 -$277.8M $0
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $0 -$125.0M -$275.0M -$52.5M $-221,000
Net Change in Cash $43.3M -$56.8M -$180.3M -$30.0M -$11.3M
Analyst Estimates (Annual)
Metric 2025 2026 2027 2028
Revenue $1.6B
$1.6B – $1.7B
 $1.7B
$1.7B – $1.7B
 $1.7B
$1.7B – $1.7B
 $1.8B
$1.8B – $1.8B
EBITDA $186.2M
$184.8M – $188.5M
 $191.4M
$190.0M – $192.6M
 $197.8M
$196.6M – $198.9M
 $204.2M
$204.2M – $204.2M
Net Income $169.0M
$167.4M – $170.5M
 $188.1M
$183.8M – $192.4M
 $199.9M
$196.8M – $203.1M
 $219.7M
$182.2M – $257.3M
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth +1.0% -1.0% +4.5% +1.5%
Gross Profit Growth +2.7% -8.8% -0.3% -4.2%
Operating Income Growth +21.1% -53.3% -74.5% +140.5%
Net Income Growth +6.8% -62.5% -110.3% -7,337.7%
EBITDA Growth +5.0% -33.4% -24.5% -268.8%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2026-03-11 Singh Harvinder A-Award 60,865.00 $0.00 $0
2026-03-11 Singh Harvinder M-Exempt 18,922.00 $0.00 $0
2026-03-11 Singh Harvinder F-InKind 5,190.00 $9.61 $49,876
2026-03-10 Singh Harvinder M-Exempt 1,216.00 $0.00 $0
2026-03-10 Singh Harvinder F-InKind 601.00 $9.55 $5,740
2026-03-11 Singh Harvinder F-InKind 861.00 $9.61 $8,274
2026-03-10 Singh Harvinder M-Exempt 1,216.00 $0.00 $0
2026-03-11 Singh Harvinder M-Exempt 2,356.00 $0.00 $0
2026-03-11 Singh Harvinder M-Exempt 16,566.00 $0.00 $0
2026-03-11 McBreen Michael J. A-Award 92,108.00 $0.00 $0
2026-03-10 McBreen Michael J. F-InKind 2,354.00 $9.55 $22,481
2026-03-11 McBreen Michael J. F-InKind 7,247.00 $9.61 $69,644
2026-03-10 DAVIS ROBERT T. JR. F-InKind 687.00 $9.55 $6,561
2026-03-11 DAVIS ROBERT T. JR. F-InKind 8,487.00 $9.61 $81,560
2026-03-11 DAVIS ROBERT T. JR. A-Award 43,350.00 $0.00 $0
2026-03-10 Mosebrook Jeffrey F-InKind 341.00 $9.55 $3,257
2026-03-11 Mosebrook Jeffrey F-InKind 806.00 $9.61 $7,746
2026-03-11 Mosebrook Jeffrey A-Award 15,957.00 $0.00 $0
2026-03-11 Knight Lea Daniels A-Award 111,179.00 $0.00 $0
2026-03-11 Knight Lea Daniels F-InKind 8,089.00 $9.61 $77,735
Community AI Feedback
Sign in to Contribute
No community reviews yet for IART. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27